In patients with Prader-Willi syndrome (PWS), a syndrome associated with congenital hypothalamic damage, hypothalamic obesity and hyperphagia, intranasal oxytocin leads to a reduction in appetite drive, and improvements in socialization, anxiety, and repetitive behaviours. Here, OXT is linked to Prader-Willi syndrome.